Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis ; volume:10 ; number:1 ; day:27 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
Scientific reports ; 10, Heft 1 (27.10.2020), 1-9, 12.2020
- Urheber
-
Romano, Micol
Piskin, David
Berard, Roberta A.
Jackson, Bradley C.
Acikel, Cengizhan
Carrero, Juan J.
Lachmann, Helen J.
Yilmaz, Mahmut I.
Demirkaya, Erkan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-75433-7
- URN
-
urn:nbn:de:101:1-2020120621064638469212
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Romano, Micol
- Piskin, David
- Berard, Roberta A.
- Jackson, Bradley C.
- Acikel, Cengizhan
- Carrero, Juan J.
- Lachmann, Helen J.
- Yilmaz, Mahmut I.
- Demirkaya, Erkan
- SpringerLink (Online service)
Ähnliche Objekte (12)
The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever
Renal and suprarenal insufficiency secondary to familial Mediterranean fever associated with amyloidosis: a case report
Familial Mediterranean Fever in older children
Posterior Scleritis in Familial Mediterranean Fever
Cardiac manifestations of Familial Mediterranean fever
Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects
Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report
The role of genotype in Familial Mediterranean Fever
Familial Mediterranean Fever: an unusual cause of liver disease
Vitamin D levels in children with familial Mediterranean fever
The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever
Renal and suprarenal insufficiency secondary to familial Mediterranean fever associated with amyloidosis: a case report
Familial Mediterranean Fever in older children
Posterior Scleritis in Familial Mediterranean Fever
Cardiac manifestations of Familial Mediterranean fever
Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects
Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report
The role of genotype in Familial Mediterranean Fever
Familial Mediterranean Fever: an unusual cause of liver disease
Vitamin D levels in children with familial Mediterranean fever
The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever
Renal and suprarenal insufficiency secondary to familial Mediterranean fever associated with amyloidosis: a case report
Familial Mediterranean Fever in older children
Posterior Scleritis in Familial Mediterranean Fever
Cardiac manifestations of Familial Mediterranean fever
Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects
Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report
The role of genotype in Familial Mediterranean Fever
Familial Mediterranean Fever: an unusual cause of liver disease